Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+T cells

被引:86
作者
Lucas, M
Vargas-Cuero, AL
Lauer, GM
Barnes, E
Willberg, CB
Semmo, N
Walker, BD
Phillips, R
Klenerman, P
机构
[1] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3SY, England
[2] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[4] Harvard Univ, Sch Med, Boston, MA 02114 USA
[5] Royal Free Hosp, Ctr Hepatol, London NW3 2QG, England
关键词
D O I
10.4049/jimmunol.172.3.1744
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies using MHC class I tetramers have shown that CD8(+) T cell responses against different persistent viruses vary considerably in magnitude and phenotype. At one extreme, hepatitis C virus (HCV)-specific CD8(+) T cell responses in blood are generally weak and have a phenotype that is perforin low and CCR7 high (early memory). At the other, specific responses to CMV are strong, perforin high, and CCR7 low (mature or effector memory). To examine the potential mechanisms behind this diversity, we compared CMV-specific responses in HCV-infected and healthy individuals. We find a striking difference in the phenotype of CMV-specific CD8(+) T cells between these groups. In the HCV-infected cohort, CMV-specific CD8(+) T cells lost markers associated with maturity; they had increased expression of CCR7 and reduced expression of Fas and perforin. They nevertheless responded to Ag in vitro in a manner similar to controls, with strong proliferation and appropriate acquisition of effector memory markers. The reduction in mature CD8 T cells in HCV-infected individuals may arise through either impairment or regulation of T cell stimulation, or through the early loss of mature T cells. Whatever the mechanism, HCV has a pervasive influence on the circulating CD8(+) T cell population, a novel feature that may be a hallmark of this infection.
引用
收藏
页码:1744 / 1753
页数:10
相关论文
共 32 条
[1]   Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections [J].
Appay, V ;
Dunbar, PR ;
Callan, M ;
Klenerman, P ;
Gillespie, GMA ;
Papagno, L ;
Ogg, GS ;
King, A ;
Lechner, F ;
Spina, CA ;
Little, S ;
Havlir, DV ;
Richman, DD ;
Gruener, N ;
Pape, G ;
Waters, A ;
Easterbrook, P ;
Salio, M ;
Cerundolo, V ;
McMichael, AJ ;
Rowland-Jones, SL .
NATURE MEDICINE, 2002, 8 (04) :379-385
[2]   Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection [J].
Bain, C ;
Fatmi, A ;
Zoulim, F ;
Zarski, JP ;
Trépo, C ;
Inchauspé, G .
GASTROENTEROLOGY, 2001, 120 (02) :512-524
[3]   The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection [J].
Barnes, E ;
Harcourt, G ;
Brown, D ;
Lucas, M ;
Phillips, R ;
Dusheiko, G ;
Klenerman, P .
HEPATOLOGY, 2002, 36 (03) :743-754
[4]   Skewed maturation of memory HIV-specific CD8 T lymphocytes [J].
Champagne, P ;
Ogg, GS ;
King, AS ;
Knabenhans, C ;
Ellefsen, K ;
Nobile, M ;
Appay, V ;
Rizzardi, GP ;
Fleury, S ;
Lipp, M ;
Förster, R ;
Rowland-Jones, S ;
Sékaly, RP ;
McMichael, AJ ;
Pantaleo, G .
NATURE, 2001, 410 (6824) :106-111
[5]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[6]   Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein [J].
Crotta, S ;
Stilla, A ;
Wack, A ;
D'Andrea, A ;
Nuti, S ;
D'Oro, U ;
Mosca, M ;
Filliponi, F ;
Brunetto, RM ;
Bonino, F ;
Abrignani, S ;
Valiante, NM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) :35-41
[7]  
Dennert G, 2002, CRIT REV IMMUNOL, V22, P1
[8]   The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes [J].
Erickson, AL ;
Kimura, Y ;
Igarashi, S ;
Eichelberger, J ;
Houghton, M ;
Sidney, J ;
McKinney, D ;
Sette, A ;
Hughes, AL ;
Walker, CM .
IMMUNITY, 2001, 15 (06) :883-895
[9]   Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C [J].
Gerlach, JT ;
Diepolder, HM ;
Jung, MC ;
Gruener, NH ;
Schraut, WW ;
Zachoval, R ;
Hoffmann, R ;
Schirren, CA ;
Santantonio, T ;
Pape, GR .
GASTROENTEROLOGY, 1999, 117 (04) :933-941
[10]   Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors [J].
Gillespie, GMA ;
Wills, MR ;
Appay, V ;
O'Callaghan, C ;
Murphy, M ;
Smith, N ;
Sissons, P ;
Rowland-Jones, S ;
Bell, JI ;
Moss, PAH .
JOURNAL OF VIROLOGY, 2000, 74 (17) :8140-8150